Cardiac allograft vasculopathy coronary angiography: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
In contrast to native coronary artery disease where there is focal, eccentric narrowing of the coronary vessels, CAV involves a more diffuse process that manifests initially as intimal thickening followed by concentric, longitudinal lesions.<ref name="pmid2795279">{{cite journal| author=Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME| title=The spectrum of coronary artery pathologic findings in human cardiac allografts. | journal=J Heart Transplant | year= 1989 | volume= 8 | issue= 5 | pages= 349-59 | pmid=2795279 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2795279 }} </ref><ref name="pmid2669276">{{cite journal| author=Billingham ME| title=Graft coronary disease: the lesions and the patients. | journal=Transplant Proc | year= 1989 | volume= 21 | issue= 4 | pages= 3665-6 | pmid=2669276 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2669276 }} </ref><ref name="pmid7798497">{{cite journal| author=Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL et al.| title=Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. | journal=J Am Coll Cardiol | year= 1995 | volume= 25 | issue= 1 | pages= 171-7 | pmid=7798497 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7798497 }} </ref><ref name="pmid16143236">{{cite journal| author=Haddad M, Pflugfelder PW, Guiraudon C, Novick RJ, McKenzie FN, Menkis A et al.| title=Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts. | journal=J Heart Lung Transplant | year= 2005 | volume= 24 | issue= 9 | pages= 1218-25 | pmid=16143236 | doi=10.1016/j.healun.2004.08.016 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16143236 }} </ref> The earliest description of coronary artery morphology in CAV was given my Gao et al.<ref name="pmid3292629">{{cite journal| author=Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA| title=Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. | journal=J Am Coll Cardiol | year= 1988 | volume= 12 | issue= 2 | pages= 334-40 | pmid=3292629 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3292629 }} </ref> According to the classification by Gao et al coronary lesions were classified as Type A, discrete stenosis, tubular stenosis, multiple stenoses in the proximal, middle and distal segments of coronary arteries; Type B, diffuse concentric narrowing of the coronary arteries with onset in the mid to distal segments; and Type C, diseased vessels, diffusely irregular with loss of small branches. However the nomenclature failed to provide prognostic significance of lesion classification. In 2010 the International Society for Heart and Lung Transplantation (ISHLT) proposed a standard nomenclature for CAV by integrating coronary angiographic findings with graft function and hemodynamics. | In contrast to native coronary artery disease where there is focal, eccentric narrowing of the coronary vessels, CAV involves a more diffuse process that manifests initially as intimal thickening followed by concentric, longitudinal lesions.<ref name="pmid2795279">{{cite journal| author=Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME| title=The spectrum of coronary artery pathologic findings in human cardiac allografts. | journal=J Heart Transplant | year= 1989 | volume= 8 | issue= 5 | pages= 349-59 | pmid=2795279 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2795279 }} </ref><ref name="pmid2669276">{{cite journal| author=Billingham ME| title=Graft coronary disease: the lesions and the patients. | journal=Transplant Proc | year= 1989 | volume= 21 | issue= 4 | pages= 3665-6 | pmid=2669276 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2669276 }} </ref><ref name="pmid7798497">{{cite journal| author=Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL et al.| title=Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. | journal=J Am Coll Cardiol | year= 1995 | volume= 25 | issue= 1 | pages= 171-7 | pmid=7798497 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7798497 }} </ref><ref name="pmid16143236">{{cite journal| author=Haddad M, Pflugfelder PW, Guiraudon C, Novick RJ, McKenzie FN, Menkis A et al.| title=Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts. | journal=J Heart Lung Transplant | year= 2005 | volume= 24 | issue= 9 | pages= 1218-25 | pmid=16143236 | doi=10.1016/j.healun.2004.08.016 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16143236 }} </ref> The earliest description of coronary artery morphology in CAV was given my Gao et al.<ref name="pmid3292629">{{cite journal| author=Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA| title=Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. | journal=J Am Coll Cardiol | year= 1988 | volume= 12 | issue= 2 | pages= 334-40 | pmid=3292629 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3292629 }} </ref> According to the classification by Gao et al coronary lesions were classified as Type A, discrete stenosis, tubular stenosis, multiple stenoses in the proximal, middle and distal segments of coronary arteries; Type B, diffuse concentric narrowing of the coronary arteries with onset in the mid to distal segments; and Type C, diseased vessels, diffusely irregular with loss of small branches. However the nomenclature failed to provide prognostic significance of lesion classification. In 2010 the International Society for Heart and Lung Transplantation (ISHLT) proposed a standard nomenclature for CAV by integrating coronary angiographic findings with graft function and hemodynamics. | ||
The ISHLT recommended nomenclature for CAV:<ref name="pmid20620917">{{cite journal| author=Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA et al.| title=International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. | journal=J Heart Lung Transplant | year= 2010 | volume= 29 | issue= 7 | pages= 717-27 | pmid=20620917 | doi=10.1016/j.healun.2010.05.017 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20620917 }} </ref> | The ISHLT recommended standard nomenclature for CAV:<ref name="pmid20620917">{{cite journal| author=Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA et al.| title=International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. | journal=J Heart Lung Transplant | year= 2010 | volume= 29 | issue= 7 | pages= 717-27 | pmid=20620917 | doi=10.1016/j.healun.2010.05.017 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20620917 }} </ref> | ||
{| style="border: 0px; font-size: 90%; margin: 0 18px;" | {| style="border: 0px; font-size: 90%; margin: 0 18px;" | ||
Revision as of 20:53, 4 August 2014
|
Cardiac allograft vasculopathy Microchapters |
|
Differentiating Cardiac allograft vasculopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cardiac allograft vasculopathy coronary angiography On the Web |
|
American Roentgen Ray Society Images of Cardiac allograft vasculopathy coronary angiography |
|
Cardiac allograft vasculopathy coronary angiography in the news |
|
Blogs on Cardiac allograft vasculopathy coronary angiography |
|
Directions to Hospitals Treating Cardiac allograft vasculopathy |
|
Risk calculators and risk factors for Cardiac allograft vasculopathy coronary angiography |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Early diagnosis of cardiac allograft vasculopathy (CAV) is of utmost importance as it allows alterations to optimal immunosuppression and risk factor modification prolonging graft survival and reducing morbidity and mortality. In most transplant centers coronary angiography is currently used to screen and diagnose transplant associated coronary artery disease.
Coronary Angiography
Previously, the diagnosis of CAV was made pathologically. However, with the advent of calcineurin-based immunosuppression post-cardiac transplant survival improved significantly and angiographic diagnosis became a standard. Currently, the International Society for Heart and Lung Transplantation (ISHLT) recommends annual invasive coronary angiography as the standard imaging technique to screen for CAV.[1] Angiographic evidence of coronary artery disease is very common after heart transplantation. In a multiinstitutional study by Constanzo et al it was demonstrated that by the end of 5 years after transplantation 42% of heart transplant subjects had angiographic evidence of graft coronary artery disease.[2]
Coronary Artery Morphology in CAV
In contrast to native coronary artery disease where there is focal, eccentric narrowing of the coronary vessels, CAV involves a more diffuse process that manifests initially as intimal thickening followed by concentric, longitudinal lesions.[3][4][5][6] The earliest description of coronary artery morphology in CAV was given my Gao et al.[7] According to the classification by Gao et al coronary lesions were classified as Type A, discrete stenosis, tubular stenosis, multiple stenoses in the proximal, middle and distal segments of coronary arteries; Type B, diffuse concentric narrowing of the coronary arteries with onset in the mid to distal segments; and Type C, diseased vessels, diffusely irregular with loss of small branches. However the nomenclature failed to provide prognostic significance of lesion classification. In 2010 the International Society for Heart and Lung Transplantation (ISHLT) proposed a standard nomenclature for CAV by integrating coronary angiographic findings with graft function and hemodynamics.
The ISHLT recommended standard nomenclature for CAV:[8]
| Classification | Severity | Definition |
|---|---|---|
| ISHLT CAV0 | Not significant | No detectable angiographic lesions |
| ISHLT CAV1 | Mild | Angiographic left main 50%, or primary vessel with maximum lesion of 70%, or any branch stenosis of 70% (including diffuse narrowing) without allograft dysfunction |
| ISHLT CAV2 | Moderate | Angiographic left main 50%; a single primary vessel 70%, or isolated branch stenosis of 70% in branches of 2 systems, without allograft dysfunction |
| ISHLT CAV3 | Severe | Angiographic left main 50%, or 2 or more primary vessels 70% stenosis, or isolated branch stenosis 70% in all 3 systems; or ISHLT CAV1 or CAV2 with allograft dysfunction (defined as left ventricular ejection fraction >45%, usually in the presence of regional wall motion abnormalities) or evidence of significant restrictive physiology |
- A “primary vessel” denotes the proximal and middle 33% of the left anterior descending artery, the left circumflex, the ramus, and the dominant or codominant right coronary artery with the posterior descending and posterolateral branches. A “secondary branch vessel” includes the distal 33% of the primary vessels or any segment within a large septal perforator, diagonals, and obtuse marginal branches or any portion of a nondominant right coronary artery. Restrictive cardiac allograft physiology is defined as symptomatic heart failure with echocardiographic E to A velocity ratio of 2 (1.5 in children), shortened isovolumetric relaxation time (60 ms), shortened deceleration time (150 ms), or restrictive hemodynamic values (right atrial pressure 12 mm Hg, pulmonary capillary wedge pressure 25 mm Hg, cardiac index 2 l/min/m2). Adapted from the 2010 ISHLT consensus statement for recommended nomenclature of CAV
Advantages
- Wide acceptability[8]
- Reduced healthcare cost compared with other novel intracoronary imaging techniques
- Ease of performance
Limitations
- Lower sensitivity compared with histopathological studies, intravascular ultrasound (IVUS) and optical coherence tomography (OCT), especially in detecting early-stage CAV[9][10][11][12] Coronary angiography assesses only the arterial lumen but not the wall per se. Studies have demonstrated that early after heart transplantation disease pathology is confined to coronary arterial wall with minimal narrowing of the lumen.
- Risk of contrast nephropathy in heart transplant subjects in whom chronic renal failure is a usual comorbidity[13]
References
- ↑ Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S; et al. (2010). "The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients". J Heart Lung Transplant. 29 (8): 914–56. doi:10.1016/j.healun.2010.05.034. PMID 20643330.
- ↑ Costanzo MR, Naftel DC, Pritzker MR, Heilman JK, Boehmer JP, Brozena SC; et al. (1998). "Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database". J Heart Lung Transplant. 17 (8): 744–53. PMID 9730422.
- ↑ Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME (1989). "The spectrum of coronary artery pathologic findings in human cardiac allografts". J Heart Transplant. 8 (5): 349–59. PMID 2795279.
- ↑ Billingham ME (1989). "Graft coronary disease: the lesions and the patients". Transplant Proc. 21 (4): 3665–6. PMID 2669276.
- ↑ Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL; et al. (1995). "Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound". J Am Coll Cardiol. 25 (1): 171–7. PMID 7798497.
- ↑ Haddad M, Pflugfelder PW, Guiraudon C, Novick RJ, McKenzie FN, Menkis A; et al. (2005). "Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts". J Heart Lung Transplant. 24 (9): 1218–25. doi:10.1016/j.healun.2004.08.016. PMID 16143236.
- ↑ Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA (1988). "Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings". J Am Coll Cardiol. 12 (2): 334–40. PMID 3292629.
- ↑ 8.0 8.1 Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA; et al. (2010). "International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010". J Heart Lung Transplant. 29 (7): 717–27. doi:10.1016/j.healun.2010.05.017. PMID 20620917.
- ↑ Nissen S (2001). "Coronary angiography and intravascular ultrasound". Am J Cardiol. 87 (4A): 15A–20A. PMID 11243599.
- ↑ St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ; et al. (1992). "Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening". Circulation. 85 (3): 979–87. PMID 1537134.
- ↑ Spes CH, Klauss V, Rieber J, Schnaack SD, Tammen AR, Uberfuhr P; et al. (1999). "Functional and morphological findings in heart transplant recipients with a normal coronary angiogram: an analysis by dobutamine stress echocardiography, intracoronary Doppler and intravascular ultrasound". J Heart Lung Transplant. 18 (5): 391–8. PMID 10363681.
- ↑ Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J; et al. (2005). "Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation". J Am Coll Cardiol. 45 (9): 1538–42. doi:10.1016/j.jacc.2004.12.076. PMID 15862431.
- ↑ Lindelöw B, Bergh CH, Herlitz H, Waagstein F (2000). "Predictors and evolution of renal function during 9 years following heart transplantation". J Am Soc Nephrol. 11 (5): 951–7. PMID 10770975.